ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
32 hedge funds and large institutions have $13.9M invested in Elevation Oncology in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 10 closing their positions.
Holders
32
Holders Change
-9
Holders Change %
-21.95%
% of All Funds
0.47%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
1
Increased
8
Reduced
7
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$237K |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$629K |
3 |
3
BlackRock
New York
|
$43.3K |
4 |
4
Two Sigma Advisers
New York
|
$55.2K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$69K |